| Brand name | Nonproprietary Name | Authorization date | Marketing authorisation holder |
|---|---|---|---|
| Iressa | gefitinib | 2009-06-24 | AstraZeneca AB |
| Gefitinib Mylan | gefitinib | 2018-09-27 | Mylan Pharmaceuticals Limited |
EMA：Drugs approved by European Medicines Agency through centralized Procedure.
HMA：Drugs approved by EU members through Mutual Recognition Procedure.
For more information check in official website of members:
| Brand name | Nonproprietary Name | Authorization date | Marketing authorisation holder |
|---|---|---|---|
| Iressa | gefitinib | 2009-06-24 | AstraZeneca AB |
| Gefitinib Mylan | gefitinib | 2018-09-27 | Mylan Pharmaceuticals Limited |